Skip to main content

Corporate insider profile

Garo H Armen Insider Trades

Garo H Armen has reported 7 open-market purchases on SEC Form 4 and is a net buyer of $30,717 across 1 company. The most recent open-market transaction was reported on Aug 21, 2026. Source: SEC Form 4 filings.

Latest reported as EXEC. CHAIR & PRINCIPAL OFF of Protagenic Therapeutics, Inc.\new (PTIX).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
7
Reported companies
1
Net open-market value
$30,717
Latest transaction
Aug 21, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 21, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFFOpen Market Purchase20,000$0.65$13,000
Aug 20, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFFOpen Market Purchase16,634$0.59$9,811
Aug 19, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFFOpen Market Purchase2,700$0.35$945.00
Aug 11, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFFOpen Market Purchase2,220$0.32$710.40
Aug 6, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFFOpen Market Purchase685$0.22$150.70
Aug 5, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFFOpen Market Purchase5,000$0.26$1,294
Jul 30, 2026Protagenic Therapeutics, Inc.\new (PTIX)EXEC. CHAIR & PRINCIPAL OFF.Open Market Purchase26,291$0.18$4,806

Common questions

Garo H Armen insider trading FAQ

Is Garo H Armen buying or selling stock?
Across all SEC Form 4 open-market filings on record, Garo H Armen is a net buyer of $30,717, with 7 open-market purchases reported. The latest transaction was reported on Aug 21, 2026.
Which companies does Garo H Armen report insider trades for?
Garo H Armen has reported open-market trades in Protagenic Therapeutics, Inc.\new (PTIX). The latest SEC-reported relationship is EXEC. CHAIR & PRINCIPAL OFF of Protagenic Therapeutics, Inc.\new (PTIX).
Where does Garo H Armen's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 935679, and refreshes this page daily.